Palmar‐plantar erythrodysesthesia syndrome following treatment with high‐dose methotrexate or high‐dose cytarabine
Sign Up to like & getrecommendations! Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30762
Abstract: Palmar‐plantar erythrodysesthesia syndrome (PPES) is an uncommon side effect of high‐dose cytarabine or methotrexate. Prior case reports of PPES have been limited, and the predisposing factors for the development of PPES remain unknown. read more here.
Keywords: plantar erythrodysesthesia; palmar plantar; high dose; dose cytarabine ... See more keywords
Oleosomes Encapsulating Sildenafil Citrate as Potential Topical Nanotherapy for Palmar Plantar Erythrodysesthesia with High Ex vivo Permeation and Deposition.
Sign Up to like & getrecommendations! Published in 2020 at "AAPS PharmSciTech"
DOI: 10.1208/s12249-020-01862-2
Abstract: Palmar plantar erythrodysesthesia (PPE) is a commonly reported skin toxicity of chemotherapeutic agents that significantly affects patients' quality of life. PPE is described as inflammation, swelling, and even cracks and ulcers in the skin of… read more here.
Keywords: plantar erythrodysesthesia; palmar plantar; permeation; sildenafil citrate ... See more keywords
Pegylated Liposomal Doxorubicin-induced Palmar-plantar Erythrodysesthesia
Sign Up to like & getrecommendations! Published in 2018 at "Gynecology and Minimally Invasive Therapy"
DOI: 10.4103/gmit.gmit_8_17
Abstract: A 44-year-old female, without previously known diseases, underwent a total hysterectomy following the diagnosis of a symptomatic myoma, about 8.4 cm × 7.9 cm. She reported lower abdominal pain and fullness for 2 weeks, without… read more here.
Keywords: pegylated liposomal; palmar plantar; plantar erythrodysesthesia; doxorubicin ... See more keywords